We need to stop the 2% reduction in reimbursement for cancer medication under medicare part b. I urge you to sign on and support HR1416. If this bill does not pass ,it will weaken the community based oncology cancer patients . More important if HR1416 does not pass,it will cost us us tax payers almost $2 billon a year. Please help
This is historical material “frozen in time”. The website is no longer updated and links to external websites and some internal pages may not work.
